Methionine restriction plus vitamin B12 antagonism overcomes methionine independence for cancer therapy
Cancer Letters · 2026-10 · 657 · 218723
DOI: 10.1016/j.canlet.2026.218723 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026-10. Verfasst von Valentin Lacombe und 10 weiteren Autor:innen. Beteiligte Einrichtung: Univ Angers, Inserm, CNRS, MITOVASC, Equipe MitoLab, SFR ICAT, Angers, F-49000, France; Service de Médecine interne et polyvalente, Centre Hospitalie…. Hauptthemen laut MEDLINE: Methionine, Vitamin B 12, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Réseau Sociétés d'Accélération du Transfert de Technologies.
Abstract (Originalsprache)
Methionine dependence represents a well-known metabolic vulnerability in cancer. Despite promising preclinical results, methionine restriction is impaired by the presence of methionine-independent cancer cells. After confirming both inter- and intra-tumoral heterogeneity in methionine dependence, we demonstrate that "methionine-independent" cells are rather "methionine self-sufficient," relying on the vitamin B12 (B12)-dependent methionine synthase (MTR) to sustain growth without exogenous methionine, which renders them highly vulnerable to B12 deprivation. Dual methionine and B12 deprivation produced synergistic cytotoxicity, inhibiting proliferation and inducing apoptosis across multiple cancer types and primary tumor cells, while sparing fibroblasts. This synergy persisted under moderate nutrient restriction, supporting translational potential. Moreover, dual therapy prevented the adaptive metabolic shift seen with methionine deprivation alone, avoiding rebound proliferation and resistance. In vivo, a methionine-restricted diet plus a synthesized B12 antagonist significantly suppressed growth of methionine-independent pancreatic xenografts without hematologic toxicity. These findings uncover a selective, synergistic anticancer strategy targeting methionine self-sufficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ Angers, Inserm, CNRS, MITOVASC, Equipe MitoLab, SFR ICAT, Angers, F-49000, France; Service de Médecine interne et polyvalente, Centre Hospitalier du Haut-Anjou, Château-Gontier, France; Service de Médecine interne…
- Univ Angers, Inserm, CNRS, MITOVASC, Equipe MitoLab, SFR ICAT, Angers, F-49000, France.
- Univ Angers, Inserm, CNRS, MITOVASC, Equipe MitoLab, SFR ICAT, Angers, F-49000, France; Service de Médecine interne et polyvalente, Centre Hospitalier du Haut-Anjou, Château-Gontier, France.
- Univ Angers, Inserm, CNRS, MITOVASC, Equipe MitoLab, SFR ICAT, Angers, F-49000, France; Service de Médecine interne et immunologie clinique, Centre Hospitalier Universitaire d'Angers, Angers, France.
- Univ Angers, Inserm, CNRS, MITOVASC, Equipe Carme, SFR ICAT, Angers, F-49000, France.
- Département de Pathologie cellulaire et tissulaire, Centre Hospitalier Universitaire d'Angers, Angers, France.
Förderung
- Réseau Sociétés d'Accélération du Transfert de Technologies
Zitieren
APA
Lacombe, V., Aurrière, J., Mellinger, A., Khiati, S., Giachetti, N., Bessaguet, F., Bellal, S., Reynier, P., Geneviève, F., Urbanski, G., & Lenaers, G. (2026). Methionine restriction plus vitamin B12 antagonism overcomes methionine independence for cancer therapy. Cancer Letters, 657, 218723. https://doi.org/10.1016/j.canlet.2026.218723
Vancouver
Lacombe V, Aurrière J, Mellinger A, Khiati S, Giachetti N, Bessaguet F, et al. Methionine restriction plus vitamin B12 antagonism overcomes methionine independence for cancer therapy. Cancer Letters. 2026;657:218723. doi:10.1016/j.canlet.2026.218723
BibTeX
@article{Lacombe2026,
author = {Lacombe, Valentin and Aurrière, Jade and Mellinger, Adélie and Khiati, Salim and Giachetti, Nicolas and Bessaguet, Flavien and Bellal, Sarah and Reynier, Pascal and Geneviève, Franck and Urbanski, Geoffrey and Lenaers, Guy},
title = {Methionine restriction plus vitamin B12 antagonism overcomes methionine independence for cancer therapy},
journal = {Cancer Letters},
year = {2026},
volume = {657},
pages = {218723},
doi = {10.1016/j.canlet.2026.218723}
}
EUVIMED